# About — BPC-157 Literature Digest

> About this site: an independent editorial project publishing plain-English summaries of BPC-157 peer-reviewed research. Not a clinic, not a vendor, not a prescription.

## What this site is

Order BPC-157 is an independent editorial project that publishes summaries of the peer-reviewed research literature on BPC-157. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The domain carries an 'order' modifier — a common search-intent prefix for people looking for commercial sources of BPC-157. This site is not one of them. The name is the search term; the content is a reading of the literature. Every page on this site describes what studies measured. None of them point toward a purchase.

BPC-157 research is concentrated in a single laboratory in Zagreb, which has produced more than 100 studies on the compound over thirty years. This site reads that literature alongside the smaller body of independent replication, the 2024-2026 systematic reviews, and the sparse human pilot data, and summarizes the findings in plain English with every quantitative claim cited.

## How this site reads the literature

Citations on this site are drawn from PubMed, PMC, and published systematic reviews. Every quantitative claim — a dose, a percentage, an outcome measure, a half-life value — maps to a specific study in the references index. Where the literature is conflicted or uncertain, the site names the conflict. Where human data does not exist, the site does not project from animal findings.

The preclinical-only status of most BPC-157 research is stated explicitly on every page that cites rodent studies. The site does not reframe animal findings as evidence of human efficacy. The BPC-157 literature is interesting and internally consistent at the preclinical level; the translation gap to humans is real and is named as such.

All pages were written against the published literature as of May 2026. Research continues to emerge; the site may not reflect findings published after this date.

## What this site does not do

This site does not provide medical advice. It does not recommend, endorse, or suggest that any person administer BPC-157 or any other compound. The dosage literature page describes what research protocols have administered to which species by which routes — not guidance for human self-administration.

This site does not sell BPC-157, link to vendors, or have any commercial relationship with any peptide supplier. No affiliate links, no sponsored content, no vendor recommendations.

BPC-157 is not FDA-approved for any indication. It is a WADA-prohibited substance. Any person considering use in a regulated context should be aware of the legal and regulatory status described in the research section.

---

A dark-botanical reading of the BPC-157 preclinical record — thirty years of tissue-repair findings, set in ink, cited to the source, and sold by no one.